Aclarion Announces Nociscan® Cost-Effectiveness Poster
Nociscan cost-effectiveness abstract poster highlights dominance over provocative discography. The 45th Annual Society for Medical Decision...
Source: globenewswire.com
Stay updated with breaking news from Economic Value Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nociscan cost-effectiveness abstract poster highlights dominance over provocative discography. The 45th Annual Society for Medical Decision...
BROOMFIELD, CO / ACCESSWIRE / October 24, 2022 / Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented
Dr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisor - read this article along with other careers information, tips and advice on BioSpace